Pros | Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | 5Y returns in the bottom 25% of the category. | - |
INDMoney rank | 8/8 | 1/8 | ||
Category | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 6 Years 6 Months | 7 Years 6 Months | ||
Fund AUM | ₹854 Cr | ₹6460 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 1.03% | 1.03% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 37 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (12.47%) Apollo Hospitals Enterprise Ltd (7.3%) Cipla Ltd (6.76%) Lupin Ltd (4.79%) Abbott India Ltd (4.56%) | Sun Pharmaceuticals Industries Ltd (12.83%) Dr Reddy's Laboratories Ltd (9.81%) Cipla Ltd (8%) Divi's Laboratories Ltd (7.48%) Aurobindo Pharma Ltd (6.04%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (99.11%) Basic Materials (0.89%) | Health (97.66%) Basic Materials (1.19%) Financial Services (1.15%) | ||
Equity % | 97.67% | 97.7% | ||
Debt % | - | - | ||
P/E | 37.58 | 31.48 | ||
P/B | 5.51 | 4.31 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.35% | 0.09% | ||
3-Month Return | -0.76% | -0.51% | ||
6-Month Return | 3.69% | 3.48% | ||
1-Year Return | -0.26% | 3.63% | ||
3-Year Return | 22.73% | 28.68% | ||
5-Year Return | 15.02% | 18.75% |
Sharpe | 0.93 | 1.25 | ||
Alpha | -0.97 | 3.97 | ||
Beta | 0.96 | 0.95 | ||
Standard Deviation | 16.06 | 15.7 | ||
Information Ratio | -0.51 | 1.26 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah | Dharmesh Kakkad,Sharmila D’mello |